Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Madison Regenerative Medicine is a high-tech biotechnology company based in Tianjin, China, dedicated to the field of regenerative medicine and tissue engineering. The company leverages its proprietary decellularization technology to develop a range of extracellular matrix (ECM) scaffolds for clinical use. Its primary products include decellularized amniotic membranes and dermal matrices used in ophthalmology, dermatology, and general surgery to promote tissue repair and regeneration. Madison's research extends into complex organ reconstruction and advanced biomaterials, positioning it as a key player in the Chinese regenerative medicine market. The company maintains a strong focus on translating academic research into clinical applications through its specialized manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 天津麦迪森再生医学.